CHINA BCT PHARMACY GROUP, INC. Operating Income
CHINA BCT PHARMACY GROUP, INC. reported Operating Income of $6.02 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-20.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2013-05-20
- CHINA BCT PHARMACY GROUP, INC. operating income (loss) for the quarter ending 2013-03-31 was $6.02M, a 50.36% decline year-over-year.
- CHINA BCT PHARMACY GROUP, INC. operating income (loss) for the quarter ending 2012-12-31 was $2.89M, a 69.62% decline year-over-year.
- CHINA BCT PHARMACY GROUP, INC. operating income (loss) for the quarter ending 2012-09-30 was $5.82M, a 53.23% decline year-over-year.
- CHINA BCT PHARMACY GROUP, INC. operating income (loss) for the quarter ending 2012-06-30 was $8.55M, a 26.44% decline year-over-year.
- CHINA BCT PHARMACY GROUP, INC. operating income (loss) for fiscal 2012 was $29.39M, a 30.36% decline from fiscal 2011.
- CHINA BCT PHARMACY GROUP, INC. operating income (loss) for fiscal 2011 was $42.20M, a 19.28% increase from fiscal 2010.
- CHINA BCT PHARMACY GROUP, INC. operating income (loss) for fiscal 2010 was $35.38M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $6.02M 10-Q · filed 2013-05-20 | $8.91M derived: sum of 2 quarters · filed 2013-05-20 | $14.73M derived: sum of 3 quarters · filed 2013-05-20 | $23.28M derived: sum of 4 quarters · filed 2013-05-20 |
| 2012-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15 | $8.71M derived: sum of 2 quarters · filed 2013-04-15 | $17.25M derived: sum of 3 quarters · filed 2013-04-15 | $29.39M 10-K · filed 2013-04-15 |
| 2012-09-30 | $5.82M 10-Q · filed 2012-11-15 | $14.37M derived: sum of 2 quarters · filed 2012-11-15 | $26.50M 10-Q · filed 2012-11-15 | $36.00M derived: sum of 4 quarters · filed 2013-05-20 |
| 2012-06-30 | $8.55M 10-Q · filed 2012-08-17 | $20.68M 10-Q · filed 2012-08-17 | $30.18M derived: sum of 3 quarters · filed 2013-05-20 | $42.63M derived: sum of 4 quarters · filed 2013-05-20 |
| 2012-03-31 | $12.13M 10-Q · filed 2013-05-20 | $21.63M derived: sum of 2 quarters · filed 2013-05-20 | $34.08M derived: sum of 3 quarters · filed 2013-05-20 | $45.70M derived: sum of 4 quarters · filed 2013-05-20 |
| 2011-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15 | $21.95M derived: sum of 2 quarters · filed 2013-04-15 | $33.57M derived: sum of 3 quarters · filed 2013-04-15 | $42.20M 10-K · filed 2013-04-15 |
| 2011-09-30 | $12.45M 10-Q · filed 2012-11-15 | $24.07M derived: sum of 2 quarters · filed 2012-11-15 | $32.70M 10-Q · filed 2012-11-15 | $42.15M derived: sum of 4 quarters · filed 2012-11-15 |
| 2011-06-30 | $11.62M 10-Q · filed 2012-08-17 | $20.25M 10-Q · filed 2012-08-17 | $29.70M derived: sum of 3 quarters · filed 2012-08-17 | $39.17M derived: sum of 4 quarters · filed 2012-08-17 |
| 2011-03-31 | $8.63M 10-Q · filed 2012-05-21 | $18.08M derived: sum of 2 quarters · filed 2012-06-12 | $27.56M derived: sum of 3 quarters · filed 2012-06-12 | $37.82M derived: sum of 4 quarters · filed 2012-06-12 |
| 2010-12-31 | $9.45M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-06-12 | $18.93M derived: sum of 2 quarters · filed 2012-06-12 | $29.18M derived: sum of 3 quarters · filed 2012-06-12 | $35.38M 10-K/A · filed 2012-06-12 |
| 2010-09-30 | $9.48M 10-Q · filed 2011-11-14 | $19.74M derived: sum of 2 quarters · filed 2011-11-14 | $25.93M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $10.26M 10-Q · filed 2011-08-15 | $16.45M 10-Q · filed 2011-08-15 |